HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

sarizotan

serotonin 5-HT1A agonist improves motor complications in rodent and primate parkinsonian models
Also Known As:
EMD128130; sarizotan hydrochloride
Networked: 19 relevant articles (2 outcomes, 6 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Bartoszyk, Gerd D: 4 articles (12/2011 - 03/2006)
2. Russ, Hermann: 3 articles (04/2008 - 03/2004)
3. Goetz, Christopher G: 3 articles (04/2008 - 03/2004)
4. Rascol, Olivier: 3 articles (04/2008 - 03/2004)
5. Damier, Philippe: 3 articles (04/2008 - 03/2004)
6. Bartoszyk, G D: 2 articles (06/2009 - 02/2004)
7. Hicking, Christine: 2 articles (04/2008 - 01/2007)
8. Laska, Eugene: 2 articles (04/2008 - 01/2007)
9. Müller, Thomas: 2 articles (04/2008 - 01/2007)
10. Nutt, John: 2 articles (04/2008 - 03/2004)

Related Diseases

1. Dyskinesias (Dyskinesia)
2. Parkinson Disease (Parkinson's Disease)
3. Parkinsonian Disorders (Parkinsonism)
4. Movement Disorders (Movement Disorder)
5. Catalepsy

Related Drugs and Biologics

1. Levodopa (L Dopa)
2. Haloperidol (Haldol)
3. Dopamine (Intropin)
4. Serotonin 5-HT1 Receptor Agonists
5. Oxidopamine (6 Hydroxydopamine)
6. 1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)
7. Serotonin (5 Hydroxytryptamine)
8. bifeprunox
9. 1- (2,3- dihydro- 1,4- benzodioxin- 5- yl)- 4- ((5- (4- fluorophenyl)- 3- pyridinyl)methyl)piperazine
10. (3- exo)- 8- benzoyl- N- (((2S)7- chloro- 2,3- dihydro- 1,4- benzodioxin- 1- yl)methyl)- 8- azabicyclo(3.2.1)octane- 3- methanamine monohydrochloride